Recent Price Movement and Market Comparison
The stock has been under pressure over the past week, registering a decline of 6.07%, in stark contrast to the Sensex, which gained 0.79% during the same period. Over the last month, the disparity widened further, with OneSource Specialty Pharma falling 11.84% while the Sensex rose by 0.95%. This divergence highlights the stock’s relative weakness amid a generally positive market environment. Year-to-date and longer-term returns for the stock are not available, but the Sensex’s gains of 9.08% YTD and 10.47% over one year provide a benchmark for comparison, underscoring the stock’s lagging performance.
Technical Indicators and Trading Activity
On the day of 21-Nov, the stock’s intraday low touched ₹1,59...
Read More





